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Drug self-administration procedures have played a critical role in the experimental analysis of psychoactive compounds, such as
cocaine, for over 50 years. While there are numerous permutations of this procedure, this paper will specifically focus on choice
procedures using concurrent schedules of intravenous drug self-administration. The aims of this paper are to first highlight the
evolution of drug choice procedures and then review the subsequent preclinical body of literature utilizing these choice procedures
to understand the environmental, pharmacological, and biological determinants of the reinforcing stimulus eﬀects of drugs. A
main rationale for this paper is our proposition that choice schedules are underutilized in investigating the reinforcing eﬀects of
drugs in assays of drug self-administration. Moreover, we will conclude with potential future directions and unexplored scientific
space for the use of drug choice procedures.
1. The Evolution of Drug Choice Procedures
Drug self-administration procedures have played a critical
role in the experimental analysis of psychoactive compounds,
such as cocaine, formore than 50 years. In general, preclinical
drug self-administration procedures are utilized for two
main scientific purposes. One purpose is in abuse liability
testing of psychoactive compounds for potential scheduling
as controlled substances by the Drug Enforcement Agency,
and there are already excellent reviews on the use of drug self-
administration procedures for this purpose, see [1, 2]. The
other main purpose of drug self-administration procedures
is in understanding the pharmacological, environmental and
biological determinants of drug-taking behavior as a model
of drug addiction. This paper will focus on the use of
concurrent-choice schedules of drug self-administration to
address this latter purpose.
Although there are numerous permutations of drug self-
administration procedures, all use the classic 3-term con-
tingency of operant conditioning to investigate the stimulus
properties of drugs [3]. This 3-term contingency can be
diagrammed as follows:
SD −→ R −→ SC , (1)
where SD designates a discriminative stimulus, R designates
a response on the part of the organism, and SC designates
a consequent stimulus. The arrows specify the contingency
that, in the presence of the discriminative stimulus SD, per-
formance of the response R will result in delivery of the
consequent stimulus SC . As a simple and common example
from a preclinical laboratory, a rat implanted with a chronic
indwelling catheter might be connected to an infusion pump
containing a dose of a psychoactive drug and placed into an
experimental chamber that contains a stimulus light and a
response lever. Contingencies can be programmed such that,
if the stimulus light is illuminated (the discriminative stim-
ulus), then depression of the response lever (the response)
will result in delivery of a drug injection (the consequent
stimulus). Conversely, if the stimulus light is not illuminated,
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then responding does not result in the delivery of the drug
injection. Under these conditions, subjects typically learn
to respond when the discriminative stimulus is present.
Consequent stimuli that increase responding leading to their
delivery are operationally defined as reinforcers, whereas
stimuli that decrease responding leading to their delivery
are defined as punishers. The contingencies that relate
discriminative stimuli, responses, and consequent stimuli are
defined by the schedule of reinforcement [4].
The first published reports of intravenous drug self-
administration used exactly this type of single-response
procedure described above to examine morphine self-
administration in morphine-dependent rats [5, 6]. Further-
more, these seminal studies demonstrated three principles
that have been commonly observed in single-response drug
self-administration procedures ever since. First, these studies
demonstrated that intravenous morphine could maintain
schedule-appropriate rates and patterns of responding lead-
ing to its delivery, indicating that morphine functioned as a
reinforcer. Second, this single-response procedure produced
a bitonic, “inverted U shaped” dose-eﬀect function relating
the unit dose of morphine in each injection to measures
of rate (either rates of responding or injection delivery).
Thus, maximal rates of self-administration were maintained
by intermediate morphine doses, and lower rates were main-
tained not only by lower morphine doses, but also by higher
doses. Importantly, this pattern of responding indicates a
dissociation between rates of self-administration maintained
by a given consequent stimulus and the reinforcing eﬃcacy
of that stimulus [7, 8], because if the research subject is
given a choice between a lower and higher dose of the same
drug, the subject will almost always choose the higher drug
dose indicating that the higher drug dose is the preferred
or more eﬃcacious reinforcer [9, 10]. Why would rates of
drug self-administration decrease as dose increases above
some apparent optimal level? As is often the case in other
pharmacology domains, the presence of a bitonic dose-eﬀect
function indicates that multiple and/or opposing drug eﬀects
are being integrated into a common dependent variable.
For example, measures of self-administration rate can be
influenced not only by the reinforcing eﬀects of a drug
(which would have the eﬀect of increasing rates), but also
by other eﬀects of the self-administered drug that can either
increase or decrease rates (e.g., eﬀects that improve or impair
motor competence or information processing). These other
drug eﬀects will be collectively referred to as “reinforcement-
independent rate-altering eﬀects” in this paper to distinguish
them from reinforcing eﬀects, and one goal of more recently
developed procedures is to dissociate reinforcing drug eﬀects
from reinforcement-independent rate-altering eﬀects.
The third and final principle revealed by these early
studies was that rates of morphine self-administration could
be altered by treatment with other drugs. These eﬀects
were interpreted to suggest treatment eﬀects on drug rein-
forcement (and by extension, to provide evidence regarding
mechanisms of drug reinforcement). However, just as self-
administration rates can be influenced by multiple eﬀects
of the self-administered drug, so these rates can also be
influenced by multiple eﬀects of a treatment drug (or of any
other experimental manipulation, such as a lesion or genetic
modification) [11, 12]. More specifically, these experimental
manipulations can alter rates of self-administration not only
by changing the reinforcing eﬀects of the self-administered
drug, but also by changing the reinforcer-independent
rate-altering eﬀects of the self-administered drug, or by
producing its own reinforcement-independent rate-altering
eﬀects. Overall, these early studies illustrated the promise
of drug self-administration as a model of drug addiction,
but they also provided a glimpse of the challenges to
interpretation of rate-based measures generated by single-
response procedures.
Since the early 1960s, preclinical drug self-administration
research has flourished, and techniques for intravenous drug
self-administration were rapidly extended to studies with
other drug classes and in other species of experimental
subjects [13, 14]. However, over the decades, drug rein-
forcement research has evolved along three divergent paths.
One path of self-administration research has retained the
use of single-response procedures initially used by Weeks
and colleagues [5, 6] and utilized more demanding and
complex schedules of reinforcement, such as progressive-
ratio and second-order schedules, than the simple fixed-ratio
schedules used by Weeks and colleagues. In general, studies
using these approaches have demonstrated that numerous
drug classes can maintain rates and patterns of responding
consistent with the hypothesis that drugs can function as
reinforcers [15]. However, these approaches have been less
successful in generating dependent measures that clearly
dissociate reinforcing drug eﬀects from reinforcement-
independent rate-altering drug eﬀects. To highlight the
prevalence of single-response procedures in the current drug
self-administration literature, we used the keyword “self-
administration” in PubMed on April 11, 2012, to retrieve
the 50 most recent preclinical studies using intravenous drug
self-administration procedures as the primary independent
variable. This “snapshot” of the literature revealed that 15 of
the 50 most recent studies used a single-response drug self-
administration procedure.
A second path of self-administration research has
retained the simple fixed-ratio schedules utilized by Weeks
and colleagues on one response lever, but incorporated
rudimentary aspects of choice by introducing an “inactive”
response option in addition to the “active” drug option. For
example, an early study by Pickens and Thompson [16] used
a two-lever self-administration procedure in which respond-
ing on one “active” lever produced intravenous cocaine
delivery under an FR1 schedule of reinforcement, whereas
responding on a second “inactive” lever had no scheduled
consequences. Schedule-appropriate responding was main-
tained exclusively on the “active” lever, and when the con-
tingencies on the two levers were reversed, rats rapidly real-
located their responding to the newly “active” lever. In our
snapshot analysis of the current self-administration litera-
ture, the majority of drug self-administration studies (32 out
of 50) used an “inactive” manipulandum. Diﬀerential rates
of responding on “active” and “inactive” manipulanda are
useful for investigating the reinforcing eﬀects of consequent
stimuli associated with the “active”manipulandum; however,
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the utility of this simple type of choice procedure is limited
for at least twomain reasons. First, although “active/inactive-
response” procedures technically employ a concurrent sched-
ule capable of generating measures of response allocation
and choice, such measures are rarely computed or reported.
Rather, investigators more commonly report measures of
response or reinforcement rate on the “active” manipulan-
dum as if it were the only response option available, and such
rate-based measures of drug reinforcement are vulnerable to
all the reinforcement-independent rate-altering drug eﬀects
described above. Second, baseline rates of behavior on the
“active” and “inactive” manipulanda are normally vastly
diﬀerent, with rates on the “inactive” manipulandum being
very low. As a result, data on “inactive” responding are pri-
marily useful for only detecting reinforcement-independent
rate-increasing eﬀects. However, because “inactive” rates are
already low, they are insensitive to reinforcer-independent
rate-decreasing eﬀects of experimental manipulations. This
is a critical issue, because most drug self-administration
studies are designed to evaluate the ability of experimental
manipulations, such as pharmacological, environmental, or
genetic variables, to decrease drug reinforcement as indicated
by decreases in drug self-administration rates. Thus, proce-
dures that use “active” and “inactive” manipulanda are not
much diﬀerent than the single-response self-administration
procedures described above.
The third and least common path of drug self-admin-
istration research has used concurrent schedules in which
responding is maintained on two or more manipulanda by
two or more motivationally relevant consequent stimuli. For
example, responding on one manipulandum might result
in delivery of a particular drug dose, and responding on a
diﬀerent, concurrently available manipulandummight result
in delivery of a diﬀerent dose of the same drug, a diﬀerent
drug, or a qualitatively diﬀerent consequent stimulus such
as food (Figure 1). These procedures are often referred to as
“choice” procedures, because subjects allocate their behavior,
or “choose,” between the available consequent stimuli, and
the relative reinforcing eﬀects of drug in comparison to
an alternative are derived from measures of behavioral
allocation (or “drug choice”) rather than behavioral rate. As
with any other type of self-administration procedure, the
self-administered drug or other experimental manipulations
might also influence overall self-administration rate by
producing reinforcement-independent rate-altering eﬀects;
however, the impact of these other eﬀects on choice measures
of drug reinforcement can be minimized by appropriate use
of manipulanda, discriminative, and alternative reinforcing
stimuli, and schedules of reinforcement. A specific example
of this dissociation is shown in Figure 1. Cocaine versus
food choice increases as the unit cocaine dose increases;
however, rates of responding display the prototypic inverted-
U shaped dose-eﬀect function. Moreover, choice procedures
generate distinct measures of behavioral allocation and
behavioral rate that permit dissociation of reinforcing eﬀects
from reinforcement-independent rate-altering eﬀects. For
example, an experimental manipulation that decreases rein-
forcing eﬃcacy of a drug might be expected to reduce drug
choice but increase choice of the alternative and produce
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Figure 1: Baseline choice between diﬀerent doses of cocaine (0–
0.1mg/kg/injection) and food pellets in rhesus monkeys (n = 4)
under a concurrent FR10 : FR100 schedule of cocaine injections
and food availability. Abscissae: unit dose of cocaine in milligrams
per kilogram per injection. Top ordinate: percent cocaine choice.
Middle ordinate: rates of responding in responses per second.
Bottom ordinate: number of choices completed. All points represent
mean data SEM obtained during the last 3 days of saline treatment.
These unpublished data demonstrate two key observations from
choice procedures. First, cocaine choice increases in a monotonic
function as the unit cocaine dose increases. Second, while rates of
responding display the prototypic, inverted-U-shaped dose-eﬀect
function, rates of responding are not predictive of cocaine choice,
nor are rates of responding predictive of the number of choices
completed per component.
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no net change in overall reinforcement rates. A specific
example of this selective eﬀect from the literature is shown
in Figure 2 examining cocaine versus food choice during
chronic treatment with the dopamine (DA)-selective releaser
m-fluoroamphetamine [17]. Conversely, a manipulation that
produces reinforcement-independent rate-altering eﬀects
(e.g., motor impairment) might be expected to reduce
overall reinforcement rates without altering drug choice. An
example of this specific eﬀect from the literature is shown
in Figure 3 examining cocaine versus food choice during
chronic treatment with the mu-opioid agonist methadone
[18]. These distinct dependent measures of reinforcing
eﬀects (represented in measures of drug choice) and
reinforcement-independent rate-altering eﬀects (represented
in measures of overall self-administration rates) are analo-
gous to the use of concurrent schedules in the closely related
field of drug discrimination research to generate dependent
measures that permit dissociation of discriminative stim-
ulus eﬀects (represented in measures of drug-appropriate
responding) from discrimination-independent rate-altering
eﬀects (represented in measures of overall rates of respond-
ing or reinforcement). Despite this apparent advantage, our
PubMed search indicated that only 3 of the 50 most recent IV
drug self-administration studies used a concurrent schedule
of reinforcement. This paucity of research with concurrent
schedules in research on the reinforcing stimulus eﬀects of
drugs stands in striking contrast to the almost exclusive
use of concurrent schedules in drug discrimination research
and suggests that concurrent schedules are underutilized in
studies of drug self-administration [19].
Although choice procedures have been underutilized,
their value has long been appreciated. As noted above,
the earliest studies of intravenous drug self-administration
used single-response procedures, but these studies were
predated by choice studies in which drug was delivered by
other routes of administration. For example, more than two
decades before the studies by Weeks and colleagues, Spragg
evaluated choice between intramuscular morphine and fruit
inmorphine-dependent chimpanzees and demonstrated that
choice was largely influenced by the state of morphine
withdrawal (such that morphine withdrawal was associ-
ated with increased probability of morphine choice) [20].
Similarly, Nichols and colleagues established responding for
oral morphine in rats and found that morphine withdrawal
increased choice of morphine over water [21]. Intravenous
drug delivery subsequently gained prominence in drug self-
administration research because it promotes a rapid onset
of drug action that facilitates learned contingencies between
responding and drug delivery. However, the rise of intra-
venous drug self-administration was also accompanied by
a growing reliance on single-response and “active/inactive”-
response procedures, perhaps because the limited lifespan
of intravenous catheters selected for procedures that require
the least initial training. Nonetheless, the use of choice
procedures persisted, especially in studies of oral drug self-
administration [13, 22] and in a small but steady series of
intravenous drug self-administration studies. The goal here
is to review the history and major findings of research on
intravenous drug choice.
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Figure 2: Eﬀects of chronic intravenous m-fluoroamphetamine
(0.1mg/kg/hr) administration on choice between cocaine and food
in rhesus monkeys (n = 4). Abscissae: unit dose of cocaine in
milligrams per kilogram per injection. Top ordinate: percent
cocaine choice. Middle ordinate: rates of responding in responses
per second. Bottom ordinate: number of choices completed. All
points represent mean data SEM obtained during the last 3
days of m-fluoroamphetamine treatment. These published data
[17] demonstrate that experimental manipulations can selectively
decrease cocaine choice without also decreasing rates of responding
and the number of choices completed. This profile would be
considered ideal for a candidate medication to treat cocaine
dependence.
Advances in Pharmacological Sciences 5
100
75
50
25
0
0 0.0032 0.01 0.032 0.1
C
oc
ai
n
e 
ch
oi
ce
 (
%
)
(a)
0 0.0032 0.01 0.032 0.1
4
3
2
1
0
R
es
po
n
se
 r
at
e 
(r
/s
)
(b)
0 0.0032 0.01 0.032 0.1
0
2
4
6
8
10
N
u
m
be
r 
of
 c
h
oi
ce
s
Unit dose cocaine (mg/kg/inj)
+saline
+0.32/hr methadone
(c)
Figure 3: Eﬀects of chronic intravenous methadone (0.32mg/kg/hr) administration on choice between cocaine and food in rhesus monkeys
(n = 3). Abscissae: unit dose of cocaine in milligrams per kilogram per injection. Top ordinate: percent cocaine choice. Middle ordinate:
rates of responding in responses per second. Bottom ordinate: number of choices completed. All points represent mean data SEM obtained
during the last 3 days of methadone treatment. These published data [18] demonstrate that experimental manipulations can selectively
decrease rates of responding and the number of choices completed without decreasing cocaine choice.
Before proceeding, two other points are worthy of
mention. First, although choice procedures are sparingly
used in preclinical studies of drug reinforcement, they have
emerged as the standard approach in clinical studies of drug
reinforcement [23, 24]. Consequently, increased preclini-
cal use of choice procedures might facilitate translational
research on drug reinforcement. Second, scientific interest in
drug reinforcement derives in large part from its presumed
role in drug addiction, and drug addiction can be defined as
a disorder of choice and behavioral allocation [25, 26]. More-
over, 5 of the 7 diagnostic criteria for substance dependence
in the revised fourth edition of the Diagnostic and Statistical
Manual (DSM) of Mental Disorders are defined by allocation
of behavior towards procurement and use of the substance
compared to other behavior maintained by nondrug and
presumably more adaptive alternative reinforcers [27]. In the
fifth edition of the DSM that is still under development,
6 of the 11 diagnostic criteria are defined by behavioral
allocations toward the procurement and use of the substance
[28]. Thus, addiction implies excessive drug choice at the
expense of more adaptive behaviors. The pharmacological,
environmental, and genetic determinants that influence drug
choice and contribute to drug addiction can be directly
studied using choice procedures.
2. Determinants of Drug Choice
2.1. Overview. While the first drug choice procedure was
published in 1940 [20] by Spragg it was not until 1972
that the first intravenous drug choice procedure was pub-
lished, approximately 10 years after intravenous drug self-
administration procedures were introduced [5]. In their
seminal study, Findley et al. [29] examined the eﬀects
of dependence and withdrawal on secobarbital and chlor-
diazepoxide preference. Since 1972, there have been 66
publications examining the determinants of drug choice,
and these publications are summarized in Table 1. The
predominant drugs examined have been cocaine (80%)
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and heroin (15%). Furthermore, nonhuman primates have
been the predominant research subjects (81%) utilized in
these studies, with rhesus monkeys (70%) being the most
commonly used species. The results and implications of this
literature will be reviewed in more detail below.
2.2. Choice between Drug and Itself
2.2.1. Eﬀect of Dose. One of the first fundamental research
questions to be answered was whether drug choice was
dose-dependent. This question was important in deter-
mining whether drug choice varied independently of rates
of responding as drug dose increased, such that, choice
would increase and response rates decrease as a function of
increasing drug doses. Although this specific experimental
question has only been explicitly examined using intravenous
cocaine as the reinforcer and rhesus monkeys as the research
subjects, animals almost always choose the larger drug dose
[9, 30–33]. Furthermore, in the manuscripts that did report
rates of responding, there was no systematic relationship
between cocaine choice and rates of cocaine-maintained
responding [30, 34]. Overall, this body of literature supports
the conclusion that drug choice is dose-dependent and that
drug choice may be less sensitive than single-response proce-
dures to reinforcer-independent rate-altering drug eﬀects.
2.2.2. Eﬀect of Temporal Parameters of Reinforcer Delivery.
Another fundamental question to be answered was whether
drug choice was sensitive to manipulations in the delivery of
the drug. In general, when equal drug doses are available as
the consequence for two response options, research subjects
will allocate their behavior equally between the two response
options. However, if the infusion rate was to be varied
between the two response options, subjects will almost exclu-
sively choose the dose associated with the shorter (faster)
infusion rate [32, 35, 36]. The delay between response and
drug delivery is a related variable that has been manipulated
in choice studies [31, 37]. For example, Woolverton and
Anderson [37] systematically varied the delay between
completing the response requirement and delivery of the
intravenous drug injection. When the delay was 0 sec and the
choice was between a low (0.025mg/kg/injection) and high
(0.05mg/kg/injection) unit cocaine dose, the subjects almost
exclusively chose the high cocaine dose. However, increasing
delays in the delivery of the high cocaine dose produced
a monotonic decrease in high cocaine dose choice and a
reciprocal increase in choice of the alternative low cocaine
dose. Overall, these data support the notion that drug choice
is highly sensitive to manipulations that aﬀect the timing
or probability of reinforcer delivery and that subjects prefer
reinforcers to be delivered quickly and with no delay.
2.2.3. Eﬀect of Schedule of Reinforcement. Finally, a third
fundamental question to be addressed was whether the
programmed schedules of reinforcement influenced drug
choice. For example, when rhesus monkeys were given a
choice between identical cocaine doses, but the probability
of reinforcement was decreased such that every other FR5
(probability 50%) or every fourth FR5 (probability 25%)
completion resulted in delivery of the cocaine injection on
one of the response options, monkeys consistently chose
the response option associated with the higher probability
of reinforcement [38]. Several laboratories have examined
the eﬀects of schedule manipulations under concurrent
variable-interval (VI): VI schedules. Under a VI schedule
of reinforcement, the first response after a variable amount
of time has passed results in presentation of the reinforcer.
The variability in time is anchored at some programmed
time interval by the investigator such that, on average, the
interval of reinforcement is the anchored time, for example
600 sec. Most of the studies have examined cocaine versus
cocaine choice [30, 33, 39, 40], but a few have also examined
other drugs such as the mu-opioid agonists alfentanil [41] or
remifentanil [42] and the barbiturate methohexital [41, 42].
In general, these studies have been used to demonstrate
that drug self-administration procedures adhere well to
the predictions of the matching law, which posits that the
allocation of behavior between two response options will
match the frequency of reinforcement associated with those
options [30, 33, 39–41]. Moreover, as predicted, subjects
will chose reinforcers delivered under shorter versus longer
VI schedules. In contrast to concurrent VI: VI schedules,
only one published study has examined the eﬀects of
manipulating the response requirement under a concurrent
fixed-ratio (FR): FR schedule of choice between a drug and
itself [31]. In this study, only one of the three monkeys
was sensitive to FR manipulations such that increases in the
FR requirement decreased choice of the higher unit cocaine
dose and produced a reciprocal increase in choice of the
lower unit cocaine dose. Thus, choice behavior maintained
under concurrent FR: FR schedules appears to be more
quantal than choice behavior maintained under current VI:
VI schedules. Overall, this body of the literature suggests that
subjects prefer schedules of reinforcement that produce the
higher probability of reinforcement.
2.3. Choice between Drug and Alternatives
2.3.1. Behavioral Economic Considerations. One method to
understand how concurrently available reinforcers interact is
to apply conceptual frameworks employed by behavioral eco-
nomics [43, 44]. Based on economic theories, concurrently
available reinforcers can interact in one of three ways [44,
45]. First, concurrently available reinforcers can function as
substitutes; such that as the price of one reinforcer increases,
choice of that reinforcer decreases and is replaced by choice
of the substitute. The perfect substitute for a commodity
is itself, so that studies summarized above that considered
choice between a drug and itself could be conceptualized as
choice between substitutes. However, diﬀerent commodities
can also function as economic substitutes for each other.
For example, potato chips and pretzels can function as
substitutes, such that as the price of potato chips increases,
consumption of potato chips decreases and consumption
of pretzels increases. Secondly, concurrently available rein-
forcers can function as complements; under this condition,
as price of one reinforcer increases, choice of that reinforcer,
and choice of a complement also decreases. For example,
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peanut butter and jelly can function as complements, and as
the price of peanut butter increases, choice of both peanut
butter and jelly decreases. Finally, concurrently available
reinforcers can function as independents, such that changes in
the price and consumption of one reinforcer would have no
eﬀect on choice of an independent reinforcer. For example,
peanut butter and shoes typically function as independents,
such that as the price of peanut butter increases and
choice of peanut butter decreases, and consumption of
shoes is unlikely to change. The interaction between two
concurrently available reinforcers will be an important con-
sideration in the following sections. In general, alternative
reinforcers used in studies of drug choice are expected to
function as substitutes, but this is an empirical question.
2.3.2. Drug versus Other Drugs. To ascertain the relative
reinforcing eﬃcacy of two diﬀerent drugs in maintaining
behavior, a choice procedure could be programmed. As
stated earlier, a significant advantage of choice procedures
is that the primary dependent measure (behavioral allo-
cation or choice) is less confounded by reinforcement-
independent rate-altering drug eﬀects. Critical factors to
consider when assessing the relative reinforcing eﬃcacy
between two diﬀerent drugs are dose, pharmacokinetics, and
pharmacodynamics. The entire literature on choice between
two drugs has employed cocaine versus “drug X” choice
procedures, with “X” being the dopamine (DA) uptake
inhibitor methylphenidate [10, 31], the sodium channel
blocker procaine [46], the monoamine releaser cathinone
[47], DA agonists [48], nicotine [49], the DA uptake
inhibitor 2β-propanoyl-3β-(4tolyl)-tropane (PTT) [50], or
the mu-opioid agonists remifentanil [51] and heroin [52].
In general, these studies have reported that as dose of
the alternative drug reinforcer increased, cocaine choice
decreased. Such results are consistent with the conclusion
that the alternative drug functioned as a substitute for
cocaine. However, there were two notable exceptions. When
choice was between cocaine versus procaine [46] or cocaine
versus nicotine [49], cocaine choice predominated despite
increasing doses of procaine or nicotine or decreasing doses
of cocaine. Moreover, only one study has explicitly examined
whether two drugs function as substitutes, complements, or
independents. In monkeys choosing between cocaine and
the mu-opioid agonist remifentanil, remifentanil was found
to function as a behavioral economic substitute for cocaine
[51]. Overall, drug versus drug choice procedures can be
useful for assessing the relative reinforcing eﬃcacy of two
diﬀerent compounds and this procedure may hold utility in
abuse liability testing.
2.3.3. Drug versus Nondrug Reinforcers. Analysis of the choice
studies in Table 1 revealed that 61% (41/67) used a nondrug
alternative reinforcer with 93% (38/41) of these studies
using food and 7% (3/41) using saccharin or sucrose as
the alternative. In the first drug versus nondrug choice pro-
cedure, rhesus monkeys were allowed to choose between
cocaine injections and food in a closed economy, such that
no other food source was available outside of the choice
procedure [53]. Over the 8 experimental days, monkeys
almost exclusively choose cocaine over food despite body
weight decreases of 6 to 10% over the course of the 8
days. More recent studies have utilized other experimental
designs to evaluate the eﬀects of multiple cocaine doses
versus food using a within-session choice procedure [17, 54–
56]. For example, Figure 1 demonstrates that a complete
cocaine versus food dose-eﬀect function can be determined
within a single daily experimental session. Cocaine choice
increased in a monotonic function demonstrating that the
relative reinforcing eﬃcacy of cocaine versus food is dose-
dependent. Furthermore, this monotonic increase in cocaine
choice was in contrast to rates of responding, which displayed
the prototypic inverted U-shaped dose-eﬀect function. Thus,
the example shown in Figure 1 clearly demonstrates the dis-
sociation between using dependent measures of behavioral
allocation (choice) and behavioral rate discussed above as a
main rationale for the use of drug choice procedures.
As was evident in drug versus drug choice proce-
dures described above, the magnitude of the alternative
nondrug reinforcer, programmed schedule consequences,
and reinforcement delay were also important independent
variables that could impact drug choice [37, 55, 57–60].
For example, increasing the magnitude of the alternative
food reinforcer was shown to decrease cocaine choice [55,
57]. In another example, heroin versus food choice was
decreased by increasing the intertrial interval [60]. These
results suggest that under economic conditions where access
to reinforcers was restricted, baboons choose food over a low
dose of heroin. Moreover, if the reinforcing value of food was
decreased by providing supplemental access to food before
the cocaine versus food choice procedure, cocaine choice
increased [55, 59].
While most of the drug versus nondrug alternative choice
procedures discussed so far used nonhuman primates as
research subjects, there is a small, but growing body of
literature of drug versus food choice procedures in rodents.
For example, a recent study by Thomsen et al. [61]
established a within-session cocaine dose-eﬀect versus ensure
choice procedure similar to the within-session cocaine dose-
eﬀect versus food choice procedure shown in Figure 1. Other
rodent studies have demonstrated that introduction of an
alternative nondrug reinforcer such as a glucose/saccharin
solution [62] or food [63, 64] will attenuate cocaine or
methamphetamine choice. In contrast to these other rodent
studies, rats choosing between cocaine injections and 0.2%
saccharin never chose cocaine over the saccharin solution
[65]. This later result suggests that 0.2% saccharin is a very
strong and highly preferred reinforcer in rats. Overall, this
body of literature demonstrates that nondrug reinforcers can
decrease drug choice, but that reinforcer selection, reinforcer
magnitude, delay of reinforcement, and reinforcer access
conditions are all key independent variables to be considered
in drug versus nondrug choice procedures.
2.3.4. Drug versus Compound Consequent Stimuli. In general,
two categories of studies have investigated drug choice in
the context of another compound consequent stimulus.
One category has involved assessment of choice involving
drug plus another putative reinforcer (e.g., drug + drug or
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drug + food). For example, when contingencies were pro-
grammed such that one response option produced a high
heroin dose and a second response option produced a lower
heroin dose delivered in combination with food, monkeys
reallocated their behavior away from the high dose heroin
towards lower heroin doses plus food [66]. Other studies
have examined choice between (a) food and either cocaine
alone or cocaine + mu-opioid agonist, or (b) choice between
food and either mu agonist alone or delta-opioid + mu
agonist [67–70] and, in general, reported that the relative
reinforcing eﬃcacies of these drug mixtures were additive.
The other category has involved pairing one of the
choices with a putative punisher, such as electric shock
[71] or intravenous histamine [72, 73]. For example, Johan-
son [71] examined choice between cocaine alone versus
cocaine + electric shock. In all of these studies, the punisher
was eﬀective in decreasing choice of the reinforce + punisher
and increasing choice of the alternative reinforcer [71–
73]. However, eﬀects of punishment on drug choice could
be mitigated by increasing the drug dose [71] associated
with the punisher, decreasing the intensity of the punisher
[72, 73], or increasing the delay between delivery of the
reinforcer and delivery of the punisher [73]. Furthermore,
pairing the punisher with the alternative reinforcer can also
increase drug choice. For example, in a study of cocaine
versus food choice, histamine injections paired with cocaine
decreased cocaine choice, but if the histamine injections were
paired with food, cocaine choice increased [72]. Moreover,
these studies highlight the potential for cocaine use to
be influenced by environmental contingencies that may
govern choice of nondrug alternative reinforcers. Overall,
these results highlight the utility of concurrent schedules of
reinforcement to understand relatively sophisticated behav-
iors maintained by complex, compound consequent stimuli.
Moreover, the use of choice procedures to understand
abuse of multiple drugs, drug mixtures, and drug + other
consequent stimuli is a scientific space that remains relatively
unexplored.
2.4. Other Factors Aﬀecting Drug Choice
2.4.1. Eﬀect of Drug Dependence and Withdrawal. Most pub-
lished studies examining eﬀects of dependence and with-
drawal on drug choice have focused on opioids [66, 74–78].
In contemporary experimental designs examining choice of
mu agonists such heroin or the short-acting opioid remifen-
tanil, the total amount of opioid available during daily
choice sessions is suﬃciently limited to prevent development
of significant opioid dependence. Under these nondepen-
dent conditions, opioid choice can be eﬀectively reduced
by treatment with opioid antagonists like naloxone [76].
However, if opioid dependence is established by chronic non-
contingent opioid treatment or by permitting supplemental
daily access to contingent opioid self-administration, then
drug eﬀects on opioid choice change dramatically. So long
as dependence is maintained by opioid agonist exposure,
opioid choice during choice sessions is generally maintained
(when the alternative is food, [76, 79]) or reduced in some
subjects (when cocaine is the alternative, [78]). However,
either spontaneous withdrawal or antagonist-precipitated
withdrawal produce robust increases in opioid choice, and
this withdrawal-associated increase in opioid choice can be
blocked by opioid agonists such as methadone, which are
eﬀective maintenance medications for treatment of opioid
addiction [75, 76, 78, 79]. Overall, then, opioid withdrawal
in opioid-dependent subjects increases opioid choice, and
opioid agonists that are eﬀective maintenance medications
for treatment of opioid addiction can block this withdrawal-
associated increase in opioid choice.
In contrast to the opioid dependence literature cited
above, minimal research has been conducted examining
the eﬀects of dependence and withdrawal on drug choice
maintained by other drug classes. Consistent with the
opioid studies described above, Findley and colleagues [29]
reported that withdrawal from the barbiturate secobarbital
in secobarbital-dependent subjects increased choice of lower
secobarbital doses versus food. However, similar results have
not been demonstrated with cocaine. For example, Banks
and Negus [80] evaluated cocaine versus food choice when
subjects were exposed to and withdrawn from supplemental
daily access to cocaine self-administration under conditions
identical to those used to establish opioid dependence [76].
During supplemental cocaine access, daily cocaine intake
increased more than 10-fold and was suﬃcient to dis-
rupt performance during choice sessions; however, neither
exposure to nor withdrawal from supplemental cocaine
significantly altered cocaine versus food choice. The extent
to which drug dependence and withdrawal alters drug choice
of other drug classes, such as benzodiazepines, monoamine
releasers, or N-methyl D-aspartate antagonists, remains to be
elucidated.
2.4.2. Eﬀect of Pharmacological Variables. Another important
body of literature has examined eﬀects of pharmacological
manipulations on drug choice, either to evaluate eﬀects of
candidate antiaddiction medications or to evaluate mech-
anisms of drug reinforcement. Eﬀects of opioid agonists
and antagonists on opioid choice in nondependent and
opioid-dependent rhesus monkeys was described above, and
additional studies have investigated potential mechanisms
that may underlie withdrawal-associated increases in opioid
choice. For example, opioid withdrawal functions as a stres-
sor to activate endogenous release of the stress-related neuro-
transmitters dynorphin and corticotrophin releasing factor
(CRF). This suggested that the hypothesis that either dynor-
phin acting at kappa-opioid receptors or CRF acting at
CRF1 receptors might contribute to withdrawal-associated
increases in opioid reinforcement; however, neither the
kappa antagonist 5′-guanidinonaltrindole nor the CRF anta-
gonist antalarmin was as eﬀective as morphine in blocking
withdrawal-associated increases in opioid choice [79].
A total of 10 studies have investigated pharmacological
modulation of cocaine versus food choice. In studies exam-
ining candidate “agonist” medications for cocaine addiction,
DA-selective monoamine releasers, such as d-amphetamine
and phenmetrazine, significantly decreased cocaine choice,
whereas mixed DA-serotonin (5HT) releasers or 5HT-
selecitve releasers did not [17, 55, 81]. Importantly, these
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studies demonstrated a selective decrease in cocaine choice
without also decreasing rates of behavior, and a rep-
resentative example of this selective eﬀect is shown in
Figure 2 during treatment with the DA-selective releaser m-
fluoroamphetamine. The atypical antipsychotic and DA D2
receptor partial agonist aripiprazole also decreased cocaine
choice in rats after acute treatment, although this eﬀect
was not sustained during repeated treatment, and neither
acute nor repeated aripiprazole altered cocaine choice in
rhesus monkeys [61, 82]. Treatment with the benzodiazepine
agonist diazepam also decreased cocaine choice in rats [83].
In contrast to these studies showing decreases in cocaine
choice, cocaine choice was increased by treatment with a
5HT1A agonist, a kappa-opioid, agonist and high doses of
dopamine receptor antagonists [55, 84–86]. Finally, other
treatments that have failed to alter cocaine choice up to doses
that suppress responding include methadone and lithium
[18, 87]. Overall, this body of the literature suggests that drug
choice is sensitive to both acute and chronic pharmacological
manipulations, that pharmacological eﬀects on drug choice
can be dissociated from other drug eﬀects, and that there
is a clear need for more research in understanding the
pharmacological mechanisms of drug choice.
One final point regarding the eﬀects of pharmacological
variables on drug choice is worth mentioning. An over-
arching rationale for preclinical studies investigating the
pharmacological determinants of drug self-administration
is the development of candidate medications to treat drug
addiction. Moreover, a main goal of pharmacotherapy
should be not only to decrease drug-taking behavior, but
also to reallocate behavior to activities maintained by more
adaptive reinforcers [88]. Thus, in preclinical studies that
aspire to evaluate candidate medications for drug addiction,
choice procedures can play a critical role in the preclinical
drug development process to determine whether a given
experimental manipulation produces this critical reallocation
of behavior [19, 24]. Furthermore, human laboratory studies
provide an additional critical step in drug development
between animal studies and clinical trials, and human lab-
oratory research to evaluate eﬀects of candidate medications
on drug self-administration relies exclusively on drug versus
nondrug choice procedures [24]. Consequently, the use of
choice procedures in preclinical studies may facilitate trans-
lation of results to choice procedures in human laboratory
studies at this critical juncture in the drug development
process, and existing data suggest excellent concordance
between medication eﬀects on drug choice in animals and
humans [55, 85, 89–91].
2.4.3. Eﬀect of Other Environmental Variables. An emerging
body of research has also addressed the degree to which non-
pharmacological environmental variables might alter drug
choice. In one example, monkeys were housed in a social
context to establish a dominant-subordinate hierarchy to
examine the eﬀects of social rank on cocaine versus food
choice [92]. One main rationale for this study was that
the initial diﬀerences between dominant and subordinate
monkeys in cocaine-maintained responding under a simple
FR schedule disappeared over time as the cocaine self-
administration history progressed. Under the concurrent
FR: FR schedule of cocaine and food reinforcement, the
diﬀerences between dominant and subordinate monkeys
were recaptured. Furthermore, cocaine choice in socially
housed monkeys was decreased by manipulations of envi-
ronmental variables that were perceived to be enriching
(increased cage size), whereas cocaine choice was decreased
by environmental variables that were perceived to be stressful
(exposure to rubber snake) [56]. Another study examined
the eﬀects of ambient temperature on choice between 3,4-
methylenedioxymethamphetamine (MDMA) and food in
rhesus monkeys [93]. Compared to room temperature, cool
ambient temperatures decreased MDMA choice and warm
ambient temperatures increased MDMA choice. Similar
studies on these and other environmental variables will
play a key role in future research to identify environmental
mechanisms that may diﬀerentially aﬀect the reinforcing
strength of drugs and underlie vulnerability to or protection
from drug addiction.
2.4.4. Eﬀect of Subject-Related Biological Variables. Intraven-
ous drug choice procedures have been conducted in var-
ious species including, rats [62], squirrel monkeys [82],
cynomolgus [92] and rhesus [29] macaques, and baboons
[66]. However, there is substantial opportunity for more
systematic research on the role of these and other subject-
related variables, such as gender, genotype, or physiological
state. To the best of our knowledge, there is only one example
where a subject-related variable was manipulated in the
context of drug choice. In this study, exogenous thyroid
hormone was administered to induce a hyperthyroid state
during MDMA versus food choice [94]. Although thyroid
hormone treatment enhanced the thermogenic eﬀects of
MDMA, this treatment did not significantly alter MDMA
choice. Moreover, drug choice studies can be expected to
contribute important insights that might not be apparent
from single-response or active/inactive-response procedures.
Specifically, as has been emphasized repeatedly above, drug
choice is strongly determined by factors that influence the
reinforcing strength of alternative reinforcers. Consequently,
it should be anticipated that some subject-related variables
would have profound eﬀects on drug choice by modulating
the reinforcing strength of alternative reinforcers while
producing little or no direct changes in the reinforcing
strength of the drug.
3. Implications and Future Directions
Research on the reinforcing eﬀects of drugs has been slow
to adopt concurrent schedules of reinforcement; however,
this paper has argued that choice procedures can play a
useful role in preclinical research on drug reinforcement
and determinants of drugs use. There are still critical gaps
in our knowledge, and there remains much intellectual
space to be explored. One future direction might be the
establishment of drug versus nondrug alternative choice
procedures involving abused drugs other than the classical
compounds cocaine and heroin. The degree to which drug
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choice can be maintained by other novel drug class such as
benzodiazepines, cannabinoids, and nicotine remains to be
elucidated. Another future direction might be to examine
the impact of nondrug alternative reinforcers other than
food. Food is an easy alternative reinforcer to control
in preclinical laboratories, but there are certainly other
nondrug reinforcers (e.g., access to receptive mate or social
interactions) that are available as research tools that have yet
to be fully explored. As one example of a choice procedure
using a nondrug alternative reinforcer other than food,
one intriguing study examined eﬀects of putative anorectic
drugs on choice between food and visual access to a room
containing other monkeys [95]. This type of social reinforcer
has yet to be manipulated in studies of drug choice. Finally,
a third potential future direction is the integration of drug
reinforcers into decision-making “choice” tasks commonly
used to assess cognitive function. For example, impaired
delay discounting is a cognitive trait commonly linked
to drug abuse [96, 97], and delay discounting is often
assessed preclinically in assays that compare choice between
a delayed high-magnitude reinforcer and an immediate low-
magnitude reinforcer [98]. Strikingly, preclinical research
with this type of assay has relied exclusively on food as
the consequent stimulus. The introduction of drugs as
reinforcers into delay discounting and other cognitive tasks
may provide new insights into the relationship between
cognitive function and drug use. Overall, the body of
literature cited in this paper supports the notion that choice
procedures can facilitate data interpretation by providing a
rate-independent measure of drug reinforcement, improve
concordance between preclinical and clinical studies in
translational research, and provide experimental access to
critical independent variables that influence drug choice and
drug addiction in natural environments.
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